Statement Of Income And Retained Earnings

COSMOS Pharmaceutical Corporation - Filing #7310433

Concept 2023-06-01 to
2024-05-31
2023-06-01 to
2024-05-31
2023-06-01 to
2024-05-31
2023-06-01 to
2024-05-31
2023-06-01 to
2024-05-31
2022-06-01 to
2023-05-31
2022-06-01 to
2023-05-31
2022-06-01 to
2023-05-31
2022-06-01 to
2023-05-31
2022-06-01 to
2023-05-31
Statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
31,501,000,000 JPY
31,481,000,000 JPY
30,128,000,000 JPY
30,104,000,000 JPY
Non-operating income
Non-operating income
3,637,000,000 JPY
3,643,000,000 JPY
3,677,000,000 JPY
3,684,000,000 JPY
Non-operating expenses
Non-operating expenses
839,000,000 JPY
839,000,000 JPY
719,000,000 JPY
719,000,000 JPY
Ordinary profit (loss)
34,299,000,000 JPY
34,286,000,000 JPY
33,086,000,000 JPY
33,070,000,000 JPY
Extraordinary income
Extraordinary income
628,000,000 JPY
628,000,000 JPY
46,000,000 JPY
46,000,000 JPY
Extraordinary losses
Extraordinary losses
1,208,000,000 JPY
1,208,000,000 JPY
359,000,000 JPY
359,000,000 JPY
Profit (loss) before income taxes
33,719,000,000 JPY
33,706,000,000 JPY
32,773,000,000 JPY
32,757,000,000 JPY
Income taxes - current
9,484,000,000 JPY
9,479,000,000 JPY
9,294,000,000 JPY
9,288,000,000 JPY
Income taxes - deferred
-219,000,000 JPY
-219,000,000 JPY
-318,000,000 JPY
-318,000,000 JPY
Profit (loss)
24,446,000,000 JPY
24,446,000,000 JPY
24,446,000,000 JPY
24,454,000,000 JPY
24,446,000,000 JPY
23,797,000,000 JPY
23,787,000,000 JPY
23,787,000,000 JPY
23,787,000,000 JPY
23,787,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.